No abstract available
Keywords:
CYP polymorphism; CYP2D6; CYPC19; SNRI; Venlafaxine; antidepressants; drug induced cardiomyopathy; heart failure.
MeSH terms
-
Adult
-
Azithromycin / administration & dosage
-
Azithromycin / adverse effects
-
Cytochrome P-450 CYP2C19 / genetics*
-
Cytochrome P-450 CYP2D6 / genetics*
-
Drug Interactions / genetics
-
Heart Failure / chemically induced
-
Heart Failure / drug therapy*
-
Heart Failure / genetics
-
Heart Failure / pathology
-
Humans
-
Male
-
Pharmacogenetics
-
Pneumonia / complications
-
Pneumonia / drug therapy
-
Polymorphism, Genetic / genetics
-
Venlafaxine Hydrochloride / administration & dosage*
-
Venlafaxine Hydrochloride / adverse effects
Substances
-
Venlafaxine Hydrochloride
-
Azithromycin
-
CYP2C19 protein, human
-
Cytochrome P-450 CYP2C19
-
Cytochrome P-450 CYP2D6